Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BEN domain containing 3 pseudogene 3 (BEND3P3) is a human pseudogene, meaning it is a nonfunctional sequence in the genome related to the protein-coding gene BEN domain containing 3 (BEND3)[1][5]. BEND3P3 does not encode a functional protein and has no established biological activity, disease association, or known relevance as a drug target. Information regarding biological function and therapeutic relevance should not be inferred from this pseudogene entry. The biologically active counterpart, BEN domain containing 3 (BEND3), is a transcriptional repressor involved in chromatin organization and regulation of gene expression, but these functions do not apply to BEND3P3[1][4]. Note: If you are looking for information on the functional gene (BEND3) rather than the pseudogene (BEND3P3), please specify, as BEND3 is a functional chromatin regulator and transcriptional repressor[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BEN domain containing 3 pseudogene 3 (BEND3P3).